Nonmelanoma Skin Cancer

Facial Plastic Surgery Clinics of North America

Volumn 17, Issue 3, 2009, Pages 309-324

  Lee, David A ^a   Miller, Stanley J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Actinic keratosis; Basal cell carcinoma; Dermatofibrosarcoma protuberans; Merkel cell carcinoma; Squamous cell carcinoma

Indexed keywords

FLUOROURACIL; IMATINIB; IMIQUIMOD; PROTEIN P53; PROTEIN PATCHED; PSORALEN; STEROID;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CHROMOSOME 9Q; CLINICAL FEATURE; CRYOTHERAPY; CURETTAGE; DERMATOFIBROSARCOMA PROTUBERANS; DIFFERENTIAL DIAGNOSIS; DISTANT METASTASIS; DNA DAMAGE; ECZEMA; ELECTROSURGERY; GENE MUTATION; GENETIC RISK; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KERATOACANTHOMA; LOCAL SKIN REACTION; MERKEL CELL TUMOR; MOHS MICROGRAPHIC SURGERY; PATHOGENESIS; PHOTODYNAMIC THERAPY; PSORIASIS; PUVA; RECURRENCE RISK; REVIEW; SKIN BIOPSY; SKIN CANCER; SKIN EXAMINATION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SURGICAL TECHNIQUE; TELANGIECTASIA; ULTRAVIOLET RADIATION; VERRUCA VULGARIS;

BIOPSY, NEEDLE; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CRYOSURGERY; DERMATOFIBROSARCOMA; FACIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; LASER THERAPY; MALE; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PUVA THERAPY; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 68749107042     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2009.04.004     Document Type: Review

References (57)

1. Christenson L.J., Borrowman T.A., Vachon C.M., et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294 6 (2005) 681-690
2. Rigel D.S., Friedman R.J., and Kopf A.W. Lifetime risk for development of skin cancer in the US population: current estimate is now 1 in 5. J Am Acad Dermatol 35 6 (1996) 1012-1013
3. Madan V., Hoban P., Strange R.C., et al. Genetics and risk factors for basal cell carcinoma. Br J Dermatol 154 Suppl 1 (2006) 5-7
4. Preston D.S., and Stern R.S. Nonmelanoma cancers of the skin. N Engl J Med 327 23 (1992) 1649-1662
5. Chen G.J., Feldman S.R., Williford P.M., et al. Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg 31 1 (2005) 43-47
6. Armstrong B.K., and Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63 1-3 (2001) 8-18
7. Owens D.M. p53, chemokines, and squamous cell carcinoma. J Clin Invest 117 7 (2007) 1752-1755
8. Ponten J. Precancer: biology, importance and possible prevention, vol. 32 (1998), Cold Spring Harbor Laboratory Press, New York
9. Brantsch K.D., Meisner C., Schonfisch B., et al. Analysis of risk factors determining prognosis of cutaneous squamous cell carcinoma: a prospective study. Lancet Oncol 9 8 (2008) 713-720
10. Teh M.T., Blaydon D., Chaplin T., et al. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res 65 19 (2005) 8597-8603
11. Hutchin M.E., Kariapper M.S., Grachtchouk M., et al. Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 19 2 (2005) 214-223
12. Karagas M.R., Stannard V.A., Mott L.A., et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst 94 3 (2002) 224-226
13. Stern R.S., Liebman E.J., and Vakeva L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer: PUVA Follow-up Study. J Natl Cancer Inst 90 17 (1998) 1278-1284
14. Lichter M.D., Karagas M.R., Mott L.A., et al. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma: the New Hampshire Skin Cancer Study Group. Arch Dermatol 136 8 (2000) 1007-1011
15. Berg D., and Otley C.C. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 47 1 (2002) 1-17 [quiz: 18-20]
16. Yu R.C., Pryce D.W., Macfarlane A.W., et al. A histopathological study of 643 cutaneous horns. Br J Dermatol 124 5 (1991) 449-452
17. Rowe D.E., Carroll R.J., and Day Jr. C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 26 6 (1992) 976-990
18. Boeta-Angeles L., and Bennett R.G. Features associated with recurrence (basal cell carcinoma). In: Miller S., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 646-656
19. Haas A. Features associated with metastasis (squamous cell carcinoma). In: Miller S., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 500-505
20. Swanson N., and Johnson T.M. Management of basal and squamous cell carcinoma. In: Cummings C. (Ed). Otolaryngology head and neck surgery (1998), Mosby Yearbook, New York 486-501
21. Clayman G.L., Lee J.J., Holsinger F.C., et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 23 4 (2005) 759-765
22. Silverman M.K., Kopf A.W., Grin C.M., et al. Recurrence rates of treated basal cell carcinomas. Part 1. Overview. J Dermatol Surg Oncol 17 9 (1991) 713-718
23. Rowe D.E., Carroll R.J., and Day Jr. C.L. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 15 3 (1989) 315-328
24. Gupta A.K., Cardella C.J., and Haberman H.F. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 122 11 (1986) 1288-1293
25. Euvrard S., Kanitakis J., and Claudy A. Skin cancers after organ transplantation. N Engl J Med 348 17 (2003) 1681-1691
26. Miller S.J. Biology of basal cell carcinoma. Part II. J Am Acad Dermatol 24 2 Pt 1 (1991) 161-175
27. Brodland D. Features associated with metastasis (basal cell carcinoma). In: Miller S.J., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 657-663
28. Lowe L. Histology (basal cell carcinoma). In: Miller S.J., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 609-613
29. Maloney M., and Miller S.J. Aggressive vs nonagressive subtypes (basal cell carcinoma). In: Miller S.J., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 609-613
30. Costantino D., Lowe L., and Brown D.L. Basosquamous carcinoma-an underrecognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg 59 4 (2006) 424-428
31. Borel D.M. Cutaneous basosquamous carcinoma: review of the literature and report of 35 cases. Arch Pathol 95 5 (1973) 293-297
32. Salasche S.J. Features associated with recurrence (squamous cell carcinoma). In: Miller S., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 494-499
33. Nappi O., Pettinato G., and Wick M.R. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol 16 3 (1989) 114-121
34. Banks E.R., and Cooper P.H. Adenosquamous carcinoma of the skin: a report of 10 cases. J Cutan Pathol 18 4 (1991) 227-234
35. Barr R.J. Classification of cutaneous squamous cell carcinoma. J Cutan Pathol 18 4 (1991) 225-226
36. Breuninger H., Schaumburg-Lever G., Holzschuh J., et al. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 79 5 (1997) 915-919
37. Wolf D.J., and Zitelli J.A. Surgical margins for basal cell carcinoma. Arch Dermatol 123 3 (1987) 340-344
38. Brodland D.G., and Zitelli J.A. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 27 2 Pt 1 (1992) 241-248
39. Greene F., Page D.L., and Fleming I.D. AJCC cancer staging manual. 6th edition. (2002), AJCC Springer-Verlag, New York Berlin, Heidelberg
40. Rowe D., Caroll R.J., and Day Jr. C.L. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15 (1989) 424-431
41. Spiller W.F., and Spiller R.F. Treatment of basal cell epithelioma by curettage and electrodessication. J Am Acad Dermatol 11 5 Pt 1 (1984) 808-814
42. Barlow J.O., Zalla M.J., Kyle A., et al. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 54 6 (2006) 1039-1045
43. Bath F.J., Bong J., Perkins W., et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2 (2003) CD003412
44. Jorizzo J.L., Carney P.S., Ko W.T., et al. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule. Cutis 74 Suppl 6 (2004) 18-23
45. Saldanha G., Fletcher A., and Slater D.N. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 148 2 (2003) 195-202
46. Patel G.K., Goodwin R., Chawla M., et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 54 6 (2006) 1025-1032
47. Siddiqui M.A., Perry C.M., and Scott L.J. Topical methyl aminolevulinate. Am J Clin Dermatol 5 2 (2004) 127-137 [discussion: 138-40]
48. Pariser D.M., Lowe N.J., Stewart D.M., et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 48 2 (2003) 227-232
49. Robinson J. Follow-up and prevention (basal cell carcinoma). In: Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) p.695-8
50. Marghoob A.A., Slade J., Salopek T.G., et al. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma: screening implications. Cancer 75 Suppl 2 (1995) 707-714
51. Levi F., La Vecchia C., Te V.C., et al. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 147 8 (1998) 722-726
52. Shin D., Maloney M.E., and Lippman S.M. Follow-up and prevention (squamous cell carcinoma). In: Miller S., and Maloney M.E. (Eds). Cutaneous oncology: pathophysiology, diagnosis, and management (1998), Blackwell Science, Malden (MA) 565-570
53. Sibley R.K., Dehner L.P., and Rosai J. Primary neuroendocrine (Merkel cell?) carcinoma of the skin. I. A clinicopathologic and ultrastructural study of 43 cases. Am J Surg Pathol 9 2 (1985) 95-108
54. Ratner D., Nelson B.R., Brown M.D., et al. Merkel cell carcinoma. J Am Acad Dermatol 29 2 Pt 1 (1993) 143-156
55. Medina-Franco H., Urist M.M., Fiveash J., et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 8 3 (2001) 204-208
56. Duker I., Starz H., Bachter D., et al. Prognostic and therapeutic implications of sentinel lymphonodectomy and S-staging in Merkel cell carcinoma. Dermatology 202 3 (2001) 225-229
57. McArthur G.A. Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease. J Natl Compr Canc Netw 5 (2007) 557-562